These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 1721042)
41. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Gamero AM; Ussery D; Reintgen DS; Puleo CA; Djeu JY Cancer Res; 1995 Nov; 55(21):4988-94. PubMed ID: 7585540 [TBL] [Abstract][Full Text] [Related]
42. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC). Bonavida B; Katz J J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903 [TBL] [Abstract][Full Text] [Related]
43. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells. Kalland T; Belfrage H; Bhiladvala P; Hedlund G J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566 [TBL] [Abstract][Full Text] [Related]
44. Modulation of perforin, granzyme A, and granzyme B in murine natural killer (NK), IL2 stimulated NK, and lymphokine-activated killer cells by alcohol consumption. Spitzer JH; Meadows GG Cell Immunol; 1999 Jun; 194(2):205-12. PubMed ID: 10383823 [TBL] [Abstract][Full Text] [Related]
45. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742 [TBL] [Abstract][Full Text] [Related]
46. Granulated metrial gland cells of pregnant mouse uterus are natural killer-like cells that contain perforin and serine esterases. Parr EL; Young LH; Parr MB; Young JD J Immunol; 1990 Oct; 145(7):2365-72. PubMed ID: 1975830 [TBL] [Abstract][Full Text] [Related]
48. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Berke G Annu Rev Immunol; 1994; 12():735-73. PubMed ID: 8011296 [TBL] [Abstract][Full Text] [Related]
49. Dissociation of natural killer and lymphocyte-activated killer cell lytic activities in human CD3- large granular lymphocytes. Clément MV; Legros-Maida S; Soulie A; Guillet J; Sasportes M Eur J Immunol; 1993 Mar; 23(3):697-701. PubMed ID: 8449217 [TBL] [Abstract][Full Text] [Related]
50. Induction of activated killer cells from human lymphocytes by medullasin (a serine protease in bone marrow cells). Aoki Y; Hase T; Oshimi K; Suzuki K Immunology; 1992 Mar; 75(3):481-7. PubMed ID: 1572695 [TBL] [Abstract][Full Text] [Related]
51. Specific inhibition of interleukin 1 beta gene expression by an antisense oligonucleotide: obligatory role of interleukin 1 in the generation of lymphokine-activated killer cells. Fujiwara T; Grimm EA Cancer Res; 1992 Sep; 52(18):4954-9. PubMed ID: 1387585 [TBL] [Abstract][Full Text] [Related]
52. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity. Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549 [TBL] [Abstract][Full Text] [Related]
53. Peritoneal exudate lymphocyte and mixed lymphocyte culture hybridomas are cytolytic in the absence of cytotoxic cell proteinases and perforin. Helgason CD; Prendergast JA; Berke G; Bleackley RC Eur J Immunol; 1992 Dec; 22(12):3187-90. PubMed ID: 1446710 [TBL] [Abstract][Full Text] [Related]
54. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Clément MV; Haddad P; Soulié A; Legros-Maida S; Guillet J; Cesar E; Sasportes M Res Immunol; 1990; 141(6):477-89. PubMed ID: 2284495 [TBL] [Abstract][Full Text] [Related]
55. [A study of perforin appearing in human lymphokine-activated killer (LAK) cells derived from spleen and peripheral blood mononuclear cells]. Kataoka K Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):352-62. PubMed ID: 1603043 [TBL] [Abstract][Full Text] [Related]
56. Target cell-directed degradation of perforin mRNA in CTL: lack of correlation with loss of protein and lytic ability. Bochan M; Hommel-Berrey G; Brahmi Z Mol Immunol; 1994 Apr; 31(5):401-10. PubMed ID: 8152443 [TBL] [Abstract][Full Text] [Related]
57. Sulfonyl fluoride serine protease inhibitors inactivate RNK-16 lymphocyte granule proteases and reduce lysis by granule extracts and perforin. Ewoldt GR; Winkler U; Powers JC; Hudig D Mol Immunol; 1992 Jun; 29(6):713-21. PubMed ID: 1603092 [TBL] [Abstract][Full Text] [Related]
58. Evidence that cytotoxic T cells and natural cytotoxic cells use different lytic mechanisms to lyse the same targets. Patek PQ; Collins JL; Cohn M Eur J Immunol; 1983 May; 13(5):433-6. PubMed ID: 6189729 [TBL] [Abstract][Full Text] [Related]
59. [Cytotoxic factor in vascular injury]. Seko Y; Yazaki Y Nihon Rinsho; 1994 Aug; 52(8):2018-23. PubMed ID: 7933579 [TBL] [Abstract][Full Text] [Related]
60. Changes in the level of perforin and its transcript during effector and target cell interactions. Kim KK; Blakely A; Zhou Z; Davis J; Clark W; Kwon BS Immunol Lett; 1993 May; 36(2):161-9. PubMed ID: 8349312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]